pH-responsive core-shell nanogels induce in situ antigen production for cancer treatment

Volume: 426, Pages: 130839 - 130839
Published: Dec 1, 2021
Abstract
Chemo-immunotherapy has the superiority of remedying malignant and metastatic tumors, and acquiring better therapeutic effect as well as prognosis than monotherapy. Herein, we report a kind of pH-responsive core-shell nanoparticles to achieve the co-delivery of oxaliplatin intermediate (oxa im) (HCLO NPs) and cytosine-guanine containing oligodeoxynucleotides (CpG) for cancer treatment. The nanoparticles comprise the core of lipid-coated calcium...
Paper Details
Title
pH-responsive core-shell nanogels induce in situ antigen production for cancer treatment
Published Date
Dec 1, 2021
Volume
426
Pages
130839 - 130839
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.